Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2011050210) METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2011/050210 International Application No.: PCT/US2010/053623
Publication Date: 28.04.2011 International Filing Date: 21.10.2010
IPC:
C12Q 1/68 (2006.01) ,A61K 31/225 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1
Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
68
involving nucleic acids
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
21
Esters, e.g. nitroglycerine, selenocyanates
215
of carboxylic acids
22
of acyclic acids, e.g. pravastatin
225
Polycarboxylic acids
Applicants:
SU, Shinsan [US/US]; US (UsOnly)
DANG, Lenny [US/US]; US (UsOnly)
GROSS, Stefan [US/US]; US (UsOnly)
JIN, Shengfang [US/US]; US (UsOnly)
FANTIN, Valeria [AR/US]; US (UsOnly)
AGIOS PHARMACEUTICALS, INC. [US/US]; 38 Sidney Street Cambridge, MA 02139, US (AllExceptUS)
Inventors:
SU, Shinsan; US
DANG, Lenny; US
GROSS, Stefan; US
JIN, Shengfang; US
FANTIN, Valeria; US
Agent:
MCCARTY, Catherine, M.; Lando & Anastasi, LLP One Main Street Eleventh Floor Cambridge, MA 02142, US
Priority Data:
61/253,82121.10.2009US
61/266,93004.12.2009US
Title (EN) METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS
(FR) PROCEDES ET COMPOSITIONS POUR DES TROUBLES RELATIFS
Abstract:
(EN) Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
(FR) L'invention concerne des procédés permettant de traiter et d'évaluer des sujets ayant des mutants néoactifs de IDH (par exemple, IDH1 or IDH2).
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)